New drug combo aims to fight bladder cancer and save the bladder
NCT ID NCT07201675
Summary
This study is testing whether a combination of two drugs, vedisertib and toripalimab, can effectively treat muscle-invasive bladder cancer while allowing patients to keep their bladder. The trial will enroll 59 adults who have not had prior cancer treatment. Participants will receive the drug combination in several stages, with their response closely monitored to see if they can avoid having their bladder surgically removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.